MPG.eBooks - Search Results

1

Pharmacoeconomic review report: Empagliflozin (Jardiance)

Published 2015

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

2

Pharmacoeconomic review report: Empagliflozin (Jardiance)

Published 2015

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

3

Cardiovascular outcomes with sodium-glucose co-transporter 2 inhibitors : a review of the clinical evidence

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

4

Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Amanda, Shane, Butcher, Robyn
Published 2019

CADTH

“...-effectiveness of sodium-glucose co-transporter 2 inhibitors for the treatment of adults with type 2 diabetes...”

Read Now

5

Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Amanda, Shane, Butcher, Robyn
Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

6

Second- and third-line pharmacotherapy for type 2 diabetes : update

Published 2013

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

7

Second- and third-line pharmacotherapy for type 2 diabetes : update

Published 2013

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

8

Pharmacoeconomic review report: Empagliflozin and Metformin fixed-dose combination (Synjardy)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

9

Clinical review report: Dapagliflozin (Forxiga)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

10

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

11

Mepolizumab (Nucala)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Adrenergic beta-2 Receptor Agonists / therapeutic use...”

Read Now

12

Icatibant for patients with type III hereditary angioedema : a review of clinical effectiveness and harms

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Bradykinin B2 Receptor Antagonists / therapeutic use...”

Read Now

13

Mepolizumab (Nucala)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Adrenergic beta-2 Receptor Agonists / therapeutic use...”

Read Now

14

Empagliflozin (Jardiance)

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

15

New drugs for type 2 diabetes : second-line therapy -- science report

Published 2017

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

16

New drugs for type 2 diabetes : second-line therapy -- science report

Published 2017

CADTH

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

17

Clinical review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

18

Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

19

Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

20

CHAD65 and CHA2DS2-VASc risk stratification tools for patients with atrial fibrillation : a review of clinical effectiveness and guidelines

by Banerjee, Srabani, Picheca, Lory
Published 2017

Canadian Agency for Drugs and Technologies in Health

“...Summary critical appraisal CHAD65 and CHA2DS2-VASc risk stratification tools...”

Narrow Search